Physician profile
Edward B Yang
NPI 1477656486
$1,719.05
in general payments reported to CMS, 2019-2025
9 companies · $395 in 2025
The $395 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.52 · 2022: $719 · 2023: $333 · 2024: $197 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492 · Education: $350 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $82.00 · Travel and Lodging: $0.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.39 |
| Education | $350.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $82.00 |
| Travel and Lodging | $0.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $451.36 | 2022 | |
| Spr Therapeutics, INC | $399.03 | 2022-2023 | Sprint Pns System |
| Solventum Corporation | $350.00 | 2025 | |
| Medtronic, INC. | $160.46 | 2024 | Intellis Adaptivestim |
| Relievant Medsystems, INC. | $156.86 | 2023 | Intracept |
| Becton, Dickinson and Company | $82.00 | 2023-2024 | Bd Introsyte |
| Si-Bone, INC. | $63.09 | 2019 | |
| Merck Sharp & Dohme LLC | $28.60 | 2019-2025 | Bridion |
| Pacira Pharmaceuticals Incorporated | $27.65 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.